Glaukos Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GKOS research report →
About the company
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma.
- CEO
- Thomas William Burns
- IPO
- 2015
- Employees
- 995
- HQ
- Aliso Viejo, CA, US
Price Chart
- Market Cap
- $8.71B
- P/E
- -45.23
- P/S
- 15.80
- P/B
- 12.83
- EV/EBITDA
- -60.49
- Div Yield
- 0.00%
- Gross Margin
- 78.08%
- Op Margin
- -15.58%
- Net Margin
- -34.34%
- ROE
- -26.46%
- ROIC
- -10.40%
- Revenue
- $507.44M · 32.33%
- Net Income
- $-187,691,000 · -28.23%
- EPS
- $-3.28 · -18.41%
- Op Income
- $-86,733,000
- FCF YoY
- 20.13%
- 52W High
- $148.62
- 52W Low
- $73.16
- 50D MA
- $129.28
- 200D MA
- $110.10
- Beta
- 0.81
- Avg Volume
- 986.87K
Get TickerSpark's AI analysis on GKOS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 25, 26 | Burns Thomas William | other | 4,059 |
| Jun 25, 26 | Gilliam Joseph E | other | 1,056 |
| Jun 25, 26 | Navratil Tomas | other | 483 |
| May 28, 26 | Foley Mark J | other | 2,987 |
| May 28, 26 | WEN LEANA | other | 2,987 |
| May 28, 26 | Stapley Marc | other | 2,987 |
| May 28, 26 | WEISNER AIMEE S | other | 2,987 |
| May 28, 26 | Kliman Gilbert H | other | 2,987 |
| May 28, 26 | Hoffmeister David F | other | 2,987 |
| May 28, 26 | Torres Denice | other | 2,987 |
Our GKOS coverage
Recent articles, reports, and earnings notes.
No research on GKOS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GKOS report →Similar companies
Peers in the same neighborhood.